Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
OncoSil Medical Ltd ( (AU:OSL) ) has shared an announcement.
OncoSil Medical Ltd has disclosed the top 20 holders of its listed options, exercisable at $0.90 and expiring on 30 June 2027, which collectively control 86.28% of the 12,082,126 options on issue. The largest positions are held by institutional nominee and custody entities such as BNP Paribas, UBS, Citicorp and HSBC, signalling that the company’s option register is highly concentrated among professional and platform investors, a structure that can influence future capital raising dynamics and market liquidity for these securities.
The most recent analyst rating on (AU:OSL) stock is a Hold with a A$0.55 price target. To see the full list of analyst forecasts on OncoSil Medical Ltd stock, see the AU:OSL Stock Forecast page.
More about OncoSil Medical Ltd
OncoSil Medical Ltd is a healthcare company focused on oncology treatments, developing and commercialising medical technologies for cancer patients. The company operates in the medical devices and therapeutics sector, targeting specialised cancer care markets where advanced treatment options are in demand.
Average Trading Volume: 61,650
Technical Sentiment Signal: Sell
Current Market Cap: A$13.22M
See more insights into OSL stock on TipRanks’ Stock Analysis page.